SCHEMBL845600

SCHEMBL845600

O=C(O)C1(O)CCCN1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9762967 1.00
SCHEMBL845602 1.00
SCHEMBL940715 0.93 CYP2C19 (0.31)
SCHEMBL3578695 0.93 CYP2C19 (0.31)
SCHEMBL4422891 0.85
SCHEMBL5072354 0.84 SLC6A1 (0.31)
SCHEMBL29549012 0.76
SCHEMBL4895937 0.74 FFAR3 (0.33)
SCHEMBL1966761 0.74
SCHEMBL6256974 0.74 FFAR3 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 352 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3436498-B1 BIODEGRADABLE AND/OR BIOABSORBABLE THERMOPLASTIC POLYURETHANES LUBRIZOL ADVANCED MAT INC (US) 2024-02-21 EP claimed
EP-4058041-B1 COMPOSITIONS FOR THE TREATMENT OF EPITHELIAL LESIONS BIOFARMA S R L (IT) 2023-11-08 EP claimed
EP-3763362-B1 METHOD OF TREATING IDIOPATHIC PULMONARY FIBROSIS MEDICINOVA INC (US) 2023-01-11 EP claimed
EP-3490609-B1 POLYMER VECTURA LTD (GB) 2021-03-31 EP claimed
EP-3315509-B1 POLYMERIZED PEPTIDE AND GEL HAVING COLLAGEN-LIKE STRUCTURE KOLA GEN PHARMA INC (JP) 2021-02-17 EP claimed
EP-2996704-B1 JOINT CARE COMPOSITION MARS INC (US) 2021-01-06 EP claimed
EP-2663366-B1 AMINO ACID COMPOUND AND USE OF SAME FOR TREATING INTRAUTERINE GROWTH RESTRICTION (IUGR) AND FOR PARENTERAL FEEDING OF EXTREMELY PREMATURE INFANTS TCHIRIKOV MICHAEL (DE) 2020-08-05 EP claimed
EP-3139912-B1 METHOD OF TREATING IDIOPATHIC PULMONARY FIBROSIS MEDICINOVA INC (US) 2020-04-08 EP claimed
EP-2593595-B1 NOVEL PEPTIDES AND USES THEREOF AVANTGEN INC (US) 2020-03-11 EP claimed
EP-3288536-B1 COMPOSITIONS COMPRISING ANAKINRA SWEDISH ORPHAN BIOVITRUM AB PUBL (SE) 2019-06-26 EP claimed
EP-0691814-B1 METHOD AND COMPOSITION FOR TREATMENT OF OSTEOPOROSIS UNIV CALIFORNIA (US) 2002-06-26 EP claimed
EP-1030677-B1 SYNERGETIC ORAL COMPOSITION COMBINING SALMON DNA WITH HYDROXYPROLINE FABRE PIERRE DERMO COSMETIQUE (FR) 2002-02-06 EP claimed
EP-0583888-B2 Water-dispersible UV light-absorbing copolymer UNILEVER PLC (GB) 2001-01-17 EP claimed
EP-0815126-B1 BICYCLIC TACHYKININS ANTAGONISTS, PREPARATION THEREOF AND THEIR USE IN PHARMACEUTICAL COMPOSITION MENARINI FARMA IND (IT) 2001-01-03 EP claimed
EP-0552516-B1 Aqueous synthetic organ-extracts RIEMSCHNEIDER RANDOLPH DR DR P (DE) 1997-09-10 EP claimed
EP-0345359-B1 NOVEL HYDROXAMIC ACID DERIVATIVE FUJI YAKUHIN KOGYO KK (JP) 1997-04-09 EP claimed
EP-0445606-B1 Novel oligopeptides, pharmaceutical composition and food containing the same, and use of oligopeptides AGENCY IND SCIENCE TECHN (JP) 1997-01-22 EP claimed
EP-0339075-B1 ACYLATED URIDINE AND CYTIDINE AND USES THEREOF PRO-NEURON, INC. (US) 1993-08-18 EP claimed
EP-0223850-B1 MEDICINES WHICH CONTAIN DERIVATIVES OF PROLINE OR HYDROXYPROLINE Hoerrmann, Wilhelm, Dr. (DE) 1990-04-11 EP claimed
EP-0047216-B1 METHOD OF SELECTIVELY INCREASING YIELD AND PURITY OF CERTAIN CRYOPRECIPITATE PROTEINS Shanbrom, Edward (US) 1985-04-03 EP claimed